|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the XIDE 10-K filed Jun 11, 2007. Net
Income (Loss) Per Share
Basic net income (loss) per share is computed using the weighted
average number of common shares outstanding for the period,
while diluted net income (loss) per share is computed assuming
conversion of all dilutive securities. Shares which are
contingently issuable under the Plan have been included as
outstanding common shares for purposes of calculating net income
(loss) per share.
Due to net losses for the fiscal years ended March 31, 2007
and 2006 and the period May 6, 2004 to March 31, 2005,
454,338, 39,218, and 621 shares of securities issuable in
connection with stock option plans, restricted stock (unvested)
and restricted stock unit plans have been excluded from the
diluted loss per share calculation because their effect would be
anti-dilutive. For the period April 1, 2004 to May 5,
2004, 5,211,000 shares of securities were excluded from the
computation of diluted earnings per share because the exercise
prices of the related options and warrants were greater than the
average market price of the common shares, and would have had an
anti-dilutive effect for that period.
As a result of the consummation of the $75 million rights
offering and the private sale of $50 million of common
stock (see Note 18), the Company issued a total of
35,712,570 shares of its common stock. Upon consummation of
the rights offering, the fair value of the Company’s common
stock was more than the rights offering’s $3.50 per
share subscription price. Accordingly, basic and diluted loss
per common share have been restated for the fiscal years ended
March 31, 2006, and the period May 6, 2004 to
March 31, 2005, to reflect a stock dividend of
576,122 shares of the Company’s common stock.
This excerpt taken from the XIDE 10-K filed Jun 29, 2005. Net Income (Loss) Per Share
Basic net income (loss) per share is computed using the weighted average number of common shares outstanding for the period, while diluted net income (loss) per share is computed assuming conversion of all dilutive securities. Shares which are contingently issuable under the Plan have been included as outstanding common shares for purposes of calculating net income per share of the Successor Company for the period May 6, 2004 to March 31, 2005. Options to purchase 3,925,000 shares of common stock and warrants to purchase 1,286,000 shares of common stock were outstanding during the period April 1, 2004 to May 5, 2004. These common stock equivalents were not included in the computation of diluted earnings per share of the Predecessor Company for the period April 1, 2004 to May 5, 2004 because the exercise prices of the options and warrants were greater than the average market price of the common shares and they would have an anti-dilutive effect. These options and warrants were cancelled upon emergence from bankruptcy. See Note 2. For fiscal years ended March 31, 2004 and 2003, the Predecessor Company incurred a net loss, therefore, dilutive common stock equivalents were not used in the calculation of loss per share as they would have an anti-dilutive effect.
This excerpt taken from the XIDE 10-Q filed Feb 14, 2005. (20) NET INCOME (LOSS) PER SHARE
Basic net income (loss) per share is computed using the weighted average number of common shares outstanding for the period, while diluted net income (loss) per share is computed assuming conversion of all dilutive securities. Shares which are contingently issuable under the Plan have been included as outstanding common shares for purposes of calculating net income per share of the Successor Company for the three months ended December 31, 2004 and the period May 6, 2004 to December 31, 2004. Options to purchase 3,925,000 shares of common stock and warrants to purchase 1,286,000 shares of common stock were outstanding during the period April 1, 2004 to May 5, 2004. These common stock equivalents were not included in the computation of diluted earnings per share of the Predecessor Company for the period April 1, 2004 to May 5, 2004 because
28
Table of ContentsEXIDE TECHNOLOGIES AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)
the exercise prices of the options and warrants were greater than the average market price of the common shares and they would have an anti-dilutive effect. These options and warrants were cancelled upon emergence from bankruptcy. See Note 2. For the three and nine months ended December 31, 2003, the Predecessor Company incurred a net loss, therefore, dilutive common stock equivalents were not used in the calculation of loss per share as they would have an anti-dilutive effect.
| EXCERPTS ON THIS PAGE:
|
| |||||||
